Sanara MedTech Inc.
SMTI
$34.73
$0.010.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 77.52% | 113.01% | -4.63% | -- | 42.51% |
| Total Depreciation and Amortization | -10.08% | -15.37% | 260.91% | -- | -37.72% |
| Total Amortization of Deferred Charges | 0.00% | 23.95% | 23.95% | -- | -24.85% |
| Total Other Non-Cash Items | -27.69% | -39.12% | 133.66% | -- | 62.47% |
| Change in Net Operating Assets | -183.73% | -131.53% | 19.68% | -- | 159.43% |
| Cash from Operations | -23.48% | -23.34% | 323.29% | -- | 288.68% |
| Capital Expenditure | 99.70% | 97.46% | -13.85% | -- | -2,895.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -3,988.41% | -- | -- |
| Cash from Investing | 99.87% | 99.15% | -1,781.00% | -- | -6,580.27% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.62% | -81.51% | 111.61% | -- | -673.15% |
| Cash from Financing | 91.62% | -103.96% | 111.61% | -- | -151.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.99% | -162.05% | 510.93% | -- | -212.25% |